Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Hans Hagberg

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

scientific article published on 10 August 2018

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

scientific article published on 30 December 2003

A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma

scientific article published on 08 October 2013

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

scientific article published on 16 January 2003

Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases

scientific article published in May 2010

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up

article

Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden

scientific article published in January 2008

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

scientific article

First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies

scientific article

Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia

scientific article published on 01 February 2005

High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results.

scientific article published on 10 November 2008

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

scientific article published on 29 September 2003

Higher concentrations of specific polychlorinated biphenyl congeners in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease ⬇️

scientific article published on October 1, 1996

Long term risk of infections in Hodgkin lymphoma long‐term survivors ⬇️

scientific article published on 07 April 2011

Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

scientific article published in November 2003

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group

scientific article

Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study

scientific article published on 29 January 2016

Occupation and occupational exposure to UV light as risk factors for hairy cell leukaemia evaluated in a case-control study ⬇️

scientific article published on October 1, 1997

Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study

scientific article

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)

scientific article published on 01 January 2006

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

scientific article published on 23 January 2003

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

scientific article published on 14 July 2010

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

scientific article published on 30 June 2011

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

scientific article published on 13 January 2017

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma

scientific article published on 23 May 2016

Reply to M. Sorigue et al

scientific article published on 08 February 2019

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma

scientific article published on 22 October 2012

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

scientific article

Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial

scientific article published in January 2002

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

scientific article published on 17 May 2019

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

scientific article

T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab.

scientific article published on 25 April 2011

The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy

scientific article published on 14 May 2020

Treatment outcome in T-cell lymphoblastic lymphoma in adults - a population-based study from the Swedish Lymphoma Registry

scientific article published on 10 March 2014

Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas

scientific article published on 17 February 2015

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)

scientific article published on 01 June 2018

Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients

scientific article published in March 2011

[Limit investigation in cancer of unknown primary site]

scientific article published on 01 October 2005

Paulina is supported by:

About Paulina

Help